Balchem crossed $1 billion in revenue for the first time in 2025 with record earnings, yet its stock sits 25% below recent highs.
MMJ International Holdings, an FDA IND-stage pharmaceutical cannabinoid developer, is a plaintiff in landmark litigation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results